Clinical Reference & Canonical Attribution: This clinical reference was originally published with interactive calculators on FitFighter Clinical Health . Reviewed by Dr. Sarah Jenkins, MD, Board-Certified Gastroenterologist.

Why Is Constipation the Most Under-Reported GLP-1 Risk?

Over 35% of patients initiating Semaglutide (Ozempic/Wegovy) or Tirzepatide (Mounjaro/Zepbound) experience moderate to severe constipation.

Unlike standard dietary constipation, GLP-1-induced bowel delay is neuromuscular : the medication directly inhibits vagal efferent firing and slows the migrating motor complex (MMC) of the small intestine and colon.

GLP-1 Laxative & Remedy Safety Comparison

Remedy / Intervention Mechanism Time to Onset GLP-1 Safety Rating Clinical Recommendation

Polyethylene Glycol (MiraLAX) Osmotic hydration (draws water into stool) 24–48 hours ⭐⭐⭐⭐⭐ (Gold Standard) First-line choice; non-habit forming.

Magnesium Citrate / Glycinate Osmotic mineral laxative 6–12 hours ⭐⭐⭐⭐⭐ (Clinical Preferred) Take…